Terug
Dagbereik
€ 100,00
€ 1.001,00
52-Weeksbereik
€ 96,50
€ 1.001,00
Volume
100
50D / 200D Gem.
€ 103,96
/
€ 108,24
Vorige Slotkoers
€ 100,00
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 26,0 | 0,2 |
| P/B | 3,9 | 3,0 |
| ROE % | 16,0 | 3,6 |
| Net Margin % | 12,7 | 3,8 |
| Rev Growth 5Y % | 4,8 | 10,0 |
| D/E | 0,5 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 6,93
€ 6,38 – € 7,66
|
1,89B | 1 |
| FY2029 |
€ 5,70
€ 5,25 – € 6,29
|
1,74B | 1 |
| FY2028 |
€ 5,31
€ 4,89 – € 5,86
|
1,65B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-20 | € 2,73 | € 2,98 | +9,2% |
| 2025-06-30 | € 1,94 | € 1,89 | -2,6% |
| 2025-02-18 | € 2,26 | € 22,50 | +895,6% |
| 2024-08-22 | € 1,71 | € 18,50 | +981,9% |
| 2024-04-18 | € 2,20 | € 7,72 | +250,9% |
| 2023-06-30 | € 1,52 | € 14,48 | +852,6% |
| 2022-12-31 | € 1,81 | € 23,54 | +1200,6% |
| 2022-06-30 | € 1,00 | € 15,15 | +1419,6% |
Dividend History
7 yr streakYield
0,00%
Payout Ratio
0,10%
Growth (3Y)
11,64%
Growth (5Y)
9,50%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Apr 22, 2025 | Apr 24, 2025 | € 4,66 | 0,45% |
| May 03, 2024 | May 07, 2024 | € 3,98 | 0,40% |
| May 09, 2023 | May 11, 2023 | € 3,81 | 0,05% |
| Jun 30, 2022 | Jul 04, 2022 | € 3,35 | 0,05% |
| Jul 07, 2021 | Jul 09, 2021 | € 3,24 | 0,36% |
| Jul 02, 2020 | Jul 06, 2020 | € 2,96 | 0,06% |
| Apr 23, 2019 | Apr 25, 2019 | € 2,54 | 0,08% |
| Apr 24, 2018 | Apr 26, 2018 | € 2,45 | 0,08% |
| Apr 24, 2017 | Apr 26, 2017 | € 2,01 | 0,09% |
| Apr 19, 2016 | Apr 21, 2016 | € 1,88 | 0,10% |
| Apr 16, 2015 | Apr 20, 2015 | € 1,56 | 0,10% |
| Mar 28, 2014 | Apr 02, 2014 | € 1,69 | 0,10% |
| Apr 22, 2013 | Apr 25, 2013 | € 1,28 | 0,07% |
| Apr 24, 2012 | Apr 30, 2012 | € 1,10 | 0,06% |
| Apr 15, 2009 | Apr 15, 2009 | € 1,83 | 0,10% |
| Apr 16, 2008 | Apr 16, 2008 | € 4,20 | 0,24% |
| Apr 18, 2007 | Apr 18, 2007 | € 4,20 | 0,24% |
| Apr 12, 2006 | Apr 12, 2006 | € 3,24 | 0,18% |
| Apr 20, 2005 | Apr 20, 2005 | € 2,96 | 0,17% |
| May 13, 2004 | May 13, 2004 | € 5,00 | 0,28% |
Belangrijkste Punten
Revenue grew 4,77% annually over 5 years — modest growth
ROE of 16,00% — decent returns on equity
Generating 9,98M in free cash flow
Dividends growing 9,50% annually over 5 years
Groei
Revenue Growth (5Y)
4,77%
Revenue (1Y)2,62%
Earnings (1Y)5,42%
FCF Growth (3Y)-62,65%
Kwaliteit
Return on Equity
16,00%
ROIC9,26%
Net Margin12,70%
Op. Margin15,84%
Veiligheid
Debt / Equity
0,51
Current Ratio2,00
Interest Coverage29,47
Waardering
P/E Ratio
25,96
Forward P/E24,71
P/B Ratio3,88
EV/EBITDA23,06
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,62% | Revenue Growth (3Y) | 2,22% |
| Earnings Growth (1Y) | 5,42% | Earnings Growth (3Y) | 22,32% |
| Revenue Growth (5Y) | 4,77% | Earnings Growth (5Y) | 15,26% |
| Profitability | |||
| Revenue (TTM) | 1,33B | Net Income (TTM) | 168,74M |
| ROE | 16,00% | ROA | 7,83% |
| Gross Margin | 26,54% | Operating Margin | 15,84% |
| Net Margin | 12,70% | Free Cash Flow (TTM) | 9,98M |
| ROIC | 9,26% | FCF Growth (3Y) | -62,65% |
| Safety | |||
| Debt / Equity | 0,51 | Current Ratio | 2,00 |
| Interest Coverage | 29,47 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,10% |
| Dividend Growth (3Y) | 11,64% | Dividend Growth (5Y) | 9,50% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 25,96 | Forward P/E | 24,71 |
| P/B Ratio | 3,88 | P/S Ratio | 3,30 |
| PEG Ratio | 5,70 | Forward PEG | N/A |
| EV/EBITDA | 23,06 | Fwd EV/EBITDA | 13,63 |
| Forward P/S | 3,12 | Fwd Earnings Yield | 4,05% |
| FCF Yield | 0,23% | ||
| Market Cap | 4,38B | Enterprise Value | 4,85B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,33B | 1,29B | 1,27B | 1,23B | 1,10B |
| Net Income | 168,74M | 160,06M | 112,77M | 156,49M | 95,60M |
| EPS (Diluted) | 3,85 | 3,69 | 2,62 | 3,63 | 2,20 |
| Gross Profit | 352,56M | 329,06M | 320,41M | 318,89M | 239,57M |
| Operating Income | 210,43M | 199,26M | 172,07M | 230,78M | 131,95M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,15B | 1,93B | 1,86B | 1,79B | 1,67B |
| Total Liabilities | 1,03B | 953,81M | 1,02B | 1,00B | 980,94M |
| Shareholders' Equity | 1,13B | 980,19M | 838,24M | 790,93M | 688,22M |
| Total Debt | 575,48M | 490,10M | 525,00M | 590,00M | 560,00M |
| Cash & Equivalents | 103,13M | 38,76M | 56,36M | 91,48M | 72,62M |
| Current Assets | 1,05B | 939,38M | 983,16M | 944,89M | 826,17M |
| Current Liabilities | 524,98M | 306,60M | 397,80M | 317,59M | 270,79M |